Zusammenfassung
Etwa 80% aller Tumorerkrankungen werden wahrscheinlich durch exogene Faktoren verursacht. Diese Schätzung beruht hauptsächlich auf retrospektiven epidemiologischen Assoziations- und Korrelationsstudien. Durch solche Studien wurde beispielsweise der Zusammenhang zwischen Tabakkonsum und der Entstehung des Bronchialkarzinoms sowie verschiedener anderer Tumorerkrankungen gesichert. In einer aktuellen Kohortenstudie, in der 44.788 Geschwisterpaare aus Skandinavien untersucht worden sind, ergaben sich nur für wenige Tumorlokalisationen (Gastrointestinaltrakt, Brust, Prostata) Hinweise für hereditäre Tumorursachen (Lichtenstein et al. 2000). Ergebnisse prospektiv geplanter Interventionsstudien mit klarem aussagefähigen Endpunkt liegen nur begrenzt vor. In einigen dieser Interventionsstudien konnte durch eine definierte Nahrungszusammensetzung (Obst/Gemüse) und durch die Applikation von Nahrungsmitteladditiva (Vitamine/Mineralien) die Tumorinzidenz und -mortalität statistisch signifikant reduziert werden. In chemopräventiven Studien mit Anwendung pharmakologischer Substanzen (z. B. Retinoide) ist dies bislang nicht zweifelsfrei gelungen. Ebenfalls problematisch ist die Abschätzung der individuellen Risikokonstellation für die Entstehung einer bestimmten Tumorerkrankung.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alberts DS, Martinez ME, Roe DJ et al. (2000) Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians’ Network. N Engl J Med 342: 1156–1162
Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330: 1029–1035
Armstrong B, Doll R (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15: 617
Becker N (1999) Epidemiologie von Tumoren In: Schmoll Hi, Höffken K, Possinger K (Hrsg) Kompendium Internistische Onkologie, 3. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 173–215
Becker N, Wahrendorf1 (1997) Krebsatlas der Bundesrepublik Deutschland 1981–1990, 3. Aufl.Springer, Berlin Heidelberg New York Tokyo
Bernstein L, Deapen D, Cerhan JR, Schwartz SM, Liff J, McGann Maloney E, Perlman JA, Ford L (1999) Tamoxifen therapy for breast cancer and endometrial cancer risk.J Natl Cancer Inst 91: 1654–1662
Block G, Patterson B, Subar A (1992) Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18: 1–29
Blot WI, Li JY, Taylor PR et al. (1993) Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population.) Natl Cancer Inst 85: 1483–1492
Bolla M, Lefur R, Ton Van J (1994) Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity oropharynx: results of a multicentric double-blind randomised study. Eur J Cancer 30A: 767
Boyle P, Veronesi U, Tubiana M (1993) European School of Oncology advisory Report to the Comission for the „Europe against Cancer Programme“–Europe against Cancer. Eur J Cancer 31 A: 1395–1405
Calle EE, Miracle McMahill HL, Thun MJ, Heath CW Jr (1995) Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women.] Natl Cancer Inst 87: 517–523
Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713–1727
De Palo G, Veronesi U, Camerini T et al. (1995) Can fenretinide protect women against ovarian cancer? J Natl Cancer Inst 87: 146–147
Deutsche Krebsgesellschaft (2000) Kurzgefasste interdisziplinäre Leitlinien 2000. Diagnose und Therapie maligner Erkrankungen.Zuckschwerdt, München Bern Wien New York
Eddy DM (1990) Screening for cervical cancer. Ann Int Med 113: 214
Ettinger B, Black DM, Mitlak BH et al. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation ( MORE) Investigators. JAMA 282: 637–645
Fernandez E, La Vecchia C, D’Avanzo B, Franceschi S, Negri E, Parazzini F (1996) Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer 73: 1431–1435
Flechter S, Black W, Harris R, Rimer B, Shapiro S (1993) Special article: report of an international workshop on screening for breast cancer. J Natl Cancer Inst 85: 1644
Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B, Speizer FE, Willett WC (1999) Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 340: 169–176
Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH (1993) Low-dose aspirin and incidence of colorectal tumors in a randomized trial.) Natl Cancer Inst 85: 1220–1224
Gerber GS, Thompson IM, Thisted R, Chodak GW (1993) Disease-specific survival following routine prostate cancer screening by digital rectal examination.JAMA 269: 61–64
Gerhardsson deVerdier M, Steineck G, Hagman U, Rieger A, Norell SE (1990) Physical activity and colon cancer:a case-referent study in Stockholm. IntJ Cancer 46: 985–989
Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, Willett WC (1993a) A prospective study of dietary fat and risk of prostate cancer.J Natl Cancer Inst 85: 1571–1579
Giovannucci E, Stampfer MJ, Colditz GA, Manson JE, Rosner BA, Longnecker M, Speizer FE, Willett WC (1993b) A comparison of prospective and retrospective assessments of diet in the study of breast cancer. Am J Epidemiol 137: 502–511
Graham S, Marshall J, Mettlin C, Rzepka T, Nemoto T, Byers T (1982) Diet in the epidemiology of breast cancer. Am J Epidemiol 116: 68
Grann VR, Panageas KS, Whang W, Antman KH, Neugut Al (1998) Decision analysis of prophylactic mastectomie and oophorectomy in BrCA 1-positive or BRCA 2-positive patients.J Clin Oncol 16: 979–985
Greenberg ER, Baron JA, Stukel TA et al. (1990) A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med 323: 789–795
Greenberg ER, Baron JA, Tosteson TD et al. (1994) A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 331: 141–147
Hardcastle JD, Thomas WM, Chamberlain J et al. (1989) Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107, 349 subjects. Lancet 1: 1160–1164
Harris R, Leininger L (1995) Clinical strategies for breast cancer screening: weighing and using the evidence. Ann Intern Med 122: 539–547
Harris JR, Lippman ME, Veronesi U, WillettW (1992) Breast cancer (1).N Engl J Med 327: 319–328
Hennekens CH, Buring JE, Manson JE et al. (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334: 1145–1149
Hopkins GJ, Kennendy TG, Carrol KK (1981) Polyunsturated fatty acids as promoters of mammary carcinogenesis induced Spraguey-Dawley rats by 7, 12-dimethylben(a)anthracene.J Natl Cancer Inst 66: 517
Howe GR, Hirohata T, Hislop TG et al. (1990) Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst 82: 561–569
Howe GR, Friedenreich CM, Jain M, Miller AB (1991) A cohort study of fat intake and risk of breast cancer.J Natl Cancer Inst 83: 336–340
Hunter DJ, Spiegelman D, Adami HO et al. (1996) Cohort studies of fat intake and the risk of breast cancer-a pooled analysis.N Engl J Med 334: 356–361
Jernstrom H, Lerman C, Ghadirian P et al. (1999) Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet 354: 1846–1850
Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS (1999) Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5: 1418–1423
Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C (1988) Screening and rescreening for colorectal cancer.A controlled trial of fecal occult blood testing in 27, 700 subjects. Cancer 62: 645–651
Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O (1989) Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark.Scand J Gastroenterol 24: 599–606
Kushi LH, Sellers TA, Potter JD, Nelson CL, Munger RG, Kaye SA, Folsom AR (1992) Dietary fat and postmenopausal breast cancer. J Natl Cancer Inst 84: 1092–1099
Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T (1994) Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 5: 276–282
Levine AM (1993) Aids-related malignancies: the emerging epidemic. J Natl Cancer Inst 85: 1382–1397
Li JY, Taylor PR, Li B et al. (1993) Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia.J Natl Cancer Inst 85: 1492–1498
Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvou M, Pukkala E, Skytthe A, Hemminski K (2000) Environmental and heritable factors in the causation of cancer. N Engl J Med 343: 78
MacLennan R, Macrae F, Bain C et al. (1995) Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project.J Natl Cancer Inst 87: 17601766
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365–1371
Martin-Moreno JM, Willett WC, Gorgojo L (1994) Dietary fat, olive oil intake and breast cancer risk.lnt J Cancer 58: 774
McLarry JW, Holiday DB, Girard WM, Yamagihara RH, Kummet TD, Greenberg SD (1995) [3-Carotene, vitain A and lung cancer chemoprevention: results of an intermediate endpoint study. Am J Clin Nutr 62 (Suppl): 14315
Mertens S (1997) Lungenkrebsrisiko hoher als bisher angenommen. Dt Arztebl 42: B-2242
Merzenich H, Boeing H, Wahrendorf J (1993) Dietary fat and sports activity as determinants for age at menarche. Am J Epidemiol 138: 217–224
Mills PK, Beeson WL, Phillips RL, Fraser GE (1989) Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 64: 598–604
Nayfield SG, Karp JE, Ford LG, Dorr FA, Kramer BS (1991) Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83: 1450–1459
Newcomb PA, Storer BE (1995) Postmenopausal hormone use and risk of large-bowel cancer.J Natl Cancer Inst 87: 1067–1071
Nystrom L, Rutqvist LE, Wall S et al. (1993) Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341: 973–978
Omenn GS, Goodman GE, Thornquist MD et al. (1996) Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.J Natl Cancer Inst 88: 1550–1559
Pastorino U, Infante M, Maioli M et al. (1993) Adjuvant treatment of stage! lung cancer with high-dose vitamin A. J Clin Oncol 11: 1216–1222
Pisani P, Parkin DM, Ferlay J (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. lntJ Cancer 55: 891–903
Ransohoff DF, Lang CA (1993) Sigmoidoscopic screening in the 1990 s. JAMA 269: 1278–1281
Raue F, Frank-Raue K, Höppner W, Frilling A (1994) Multiple endokrine Neoplasie. Dt Ärzteblatt 91: 3440–3444
Rigau J, Pique JM, Rubio E, Planas R, Tarrech JM, Bordas JM (1991) Effects of long-term sulindac therapy on colonic polyposis.Ann Intern Med 115: 952–954
Rose DP, Boyar AP, Wynder EL (1986) International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 58: 2363–2371
Schatzkin A, Lanza E, Corle D et al. (2000) Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 342: 1149–1155
Selby JV (1993) How should we screen for colorectal cancer? JAMA 269: 1294–1296
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kath, R., Schneider, C.P., Höffken, K. (2004). Prävention und Früherkennung. In: Die Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06670-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-06670-6_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-06671-3
Online ISBN: 978-3-662-06670-6
eBook Packages: Springer Book Archive